Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q4 2017 call → NOWe need to determine if management describes a situation where a proven instance is being copied into additional places with demand already visible. The key is a specific, identifiable piece of the company that works, and they are now standing up more of it, with demand already there. Looking at the transcript, there is a lot about Cynosure, international, etc. But the question is about copying a proven part of the business. Let's scan for that. One candidate: The international business. They said they had a "start-up" international business, and now it's growing double digits. But are they copying it? They mention that they are applying the same approach to Cynosure. For example, Steve says: "we are making good progress toward building what we call Cynosure 2.0, which we expect to include the greatest commercial organization that the laser industry has ever seen." And later: "This process starts with great leadership, just as it did with our international business in 2016." So they are using the same playbook that worked for international to fix Cynosure. But is that a "copy" of a proven instance? The international business is proven, and they are applying its model to Cynosure. However, is Cynosure a "copy" of the international business? Not exactly. They are applying leadership and sales model. But the question asks: "the company is right now standing up further instances of that same piece in other locations, customers, markets, channels, applications, or lines." So the proven instance is the international business model, and they are applying it to Cynosure. But is that a "copy" of the same piece? The international business is a division, and Cynosure is a different division. They are not replicating the international business into new geographies; they are using its management approach to fix another business. That might not fit. Another candidate: The Panther system. They have shipped about 1,300 Panthers, and they are expanding the menu. But are they copying the Panther into new places? They are selling more Panthers, but that's just growth of the same product. Not a replication of a proven unit into new instances. Another: The 3D mammography. They have sold 4,700 units, and they are still penetrating. But that's just continued sales, not a replication. Another: The MyoSure MANUAL is a new product, but not a copy. Another: The Cynosure itself.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.